Editorial
. 2010 May;57(5):774-6; author reply 776-7.
doi: 10.1016/j.eururo.2010.01.004.
Epub 2010 Jan 14.
New insights in intravesical treatment for intermediate- and high-risk non-muscle-invasive urothelial bladder carcinoma
- PMID: 20080332
- DOI: 10.1016/j.eururo.2010.01.004
Item in Clipboard
Editorial
New insights in intravesical treatment for intermediate- and high-risk non-muscle-invasive urothelial bladder carcinoma
Eur Urol.
2010 May.
No abstract available
Comment on
-
Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder.Eur Urol. 2010 May;57(5):766-73. doi: 10.1016/j.eururo.2009.12.024. Epub 2009 Dec 18. Eur Urol. 2010. PMID: 20034729 Free PMC article. Clinical Trial.
Similar articles
-
Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.Expert Opin Drug Deliv. 2008 Jan;5(1):137-45. doi: 10.1517/17425247.5.1.137. Expert Opin Drug Deliv. 2008. PMID: 18095933 Review.
-
Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma.Eur Urol. 2007 Oct;52(4):1123-29. doi: 10.1016/j.eururo.2007.02.063. Epub 2007 Mar 12. Eur Urol. 2007. PMID: 17383080 Clinical Trial.
-
Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.Eur Urol. 2007 Oct;52(4):1129-30. doi: 10.1016/j.eururo.2007.02.064. Eur Urol. 2007. PMID: 17383082 No abstract available.
-
Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer.Eur Urol. 2008 May;53(5):984-91. doi: 10.1016/j.eururo.2007.12.033. Epub 2007 Dec 27. Eur Urol. 2008. PMID: 18248876 Clinical Trial.
-
Urothelial cancers: using biology to improve outcomes.Expert Rev Anticancer Ther. 2012 Jan;12(1):87-98. doi: 10.1586/era.11.195. Expert Rev Anticancer Ther. 2012. PMID: 22149435 Review.
Cited by
-
Peripheral blood mononuclear cells inhibit proliferation and promote apoptosis of HeLa cells following stimulation with Bacillus Calmette-Guerin.Exp Ther Med. 2013 Feb;5(2):561-566. doi: 10.3892/etm.2012.855. Epub 2012 Dec 10. Exp Ther Med. 2013. PMID: 23404059 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
